Trofinetide is a synthetic analog of glycine–proline–glutamate, the N-terminal tripeptide of the insulin-like growth factor 1 protein, and has demonstrated clinical benefit in phase 2 studies in Rett syndrome.
CAT No: R1973
CAS No:853400-76-7
Synonyms/Alias:Trofinetide;853400-76-7;NNZ-2566;DAYBUE;Trofinetide [INN];trofinetida;L-Glutamic acid, glycyl-2-methyl-L-prolyl-;UNII-Z2ME8F52QL;ACP-2566;Z2ME8F52QL;Trofinetide [USAN];glycyl-L-2-methylprolyl-L-glutamic acid;Trofinetide(NNZ2566);Glycyl-2-methyl-L-prolyl-L-glutamic acid;(2S)-2-[[(2S)-1-(2-aminoacetyl)-2-methylpyrrolidine-2-carbonyl]amino]pentanedioic acid;Trofinetide (>90%);((S)-1-glycyl-2-methylpyrrolidine-2-carbonyl)-L-glutamic acid;trofinetidum;Glycyl-2-methyl-L-prolyl-L-glutamic Acid; Glycyl-L-2-methylprolyl-L-glutamic Acid; NNZ 2566;NNZ 2566;Daybue (TN);Trofinetide (USAN/INN);Trofinetide [USAN:INN];TROFINETIDE [WHO-DD];CHEMBL197084;SCHEMBL1170014;GTPL12482;NNZ2566;CHEBI:229599;DTXSID101336041;GLXC-15737;DJB40076;EX-A7815;WHO 10076;AKOS030607026;analogue 4 [PMID: 15837309];AT37725;CS-8154;DB06045;DA-68364;HY-16757;MS-24628;glycyl-alpha-methyl-L-prolyl-L-glutamic acid;D12400;Q27294917;
Chemical Name:(2S)-2-[[(2S)-1-(2-aminoacetyl)-2-methylpyrrolidine-2-carbonyl]amino]pentanedioic acid
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.